Lately, enhanced CD47 expression was linked to CD123 expression and shown to be responsible for drug resistance in AML that could be overcome by treatment with the histone deacetylase inhibitor Romidepsin [126]. This evidence concerns the gene CD47 and acute myeloid leukemia.